Literature DB >> 34411324

In vivo spectral editing of phosphorylethanolamine.

Steve C N Hui1,2, Helge J Zöllner1,2, Georg Oeltzschner1,2, Richard A E Edden1,2, Muhammad G Saleh3.   

Abstract

PURPOSE: To demonstrate J-difference editing of phosphorylethanolamine (PE) with chemical shifts at 3.22 (PE3.22 ) and 3.98 (PE3.98 ) ppm, and compare the merits of two editing strategies.
METHODS: Density-matrix simulations of MEGA-PRESS (Mescher-Garwood PRESS) for PE were performed at TEs ranging from 80 to 200 ms in steps of 2 ms, applying 20-ms editing pulses (ON/OFF) at (1) 3.98/7.5 ppm to detect PE3.22 and (2) 3.22/7.5 ppm to detect PE3.98 . Phantom experiments were performed using a PE phantom to validate simulation results. Ten subjects were scanned using a Philips 3T MRI scanner at TEs of 90 ms and 110 ms to edit PE3.22 and PE3.98 . Osprey was used for data processing, modeling, and quantification.
RESULTS: Simulations show substantial TE modulation of the intensity and shape of the edited signals due to coupling evolution. Simulated and phantom integrals suggest that TEs of 110 ms and 90 ms were optimal for the edited detection of PE3.22 and PE3.98 , respectively. Phantom results indicated strong agreement with the simulated spectra and integrals. In vivo quantification of the PE3.22 /total creatine and PE3.98 /total creatine concentration ratio yielded values of 0.26 ± 0.04 (between-subject coefficient of variation [CV]: 15.4%) and 0.18 ± 0.04 (CV: 22.8%), respectively, at TE = 90 ms, and 0.24 ± 0.02 (CV: 8.2%) and 0.23 ± 0.04 (CV: 18.0%), respectively, at TE = 110 ms.
CONCLUSION: Simulations and in vivo MEGA-PRESS of PE demonstrate that both PE3.22 and PE3.98 are potential candidates for editing, but PE3.22 at TE = 110 ms yields lower variation across TEs.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  MEGA-PRESS; Magnetic resonance spectroscopy; magnetic resonance spectroscopy; phosphorylethanolamine; spectral editing; spectral editing phosphorylethanolamine.

Mesh:

Substances:

Year:  2021        PMID: 34411324      PMCID: PMC8616810          DOI: 10.1002/mrm.28976

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  35 in total

1.  Proton NMR chemical shifts and coupling constants for brain metabolites.

Authors:  V Govindaraju; K Young; A A Maudsley
Journal:  NMR Biomed       Date:  2000-05       Impact factor: 4.044

2.  In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors.

Authors:  J Star-Lack; D Spielman; E Adalsteinsson; J Kurhanewicz; D J Terris; D B Vigneron
Journal:  J Magn Reson       Date:  1998-08       Impact factor: 2.229

3.  Absolute quantification of phospholipid metabolites in brain-tissue extracts by 1H NMR spectroscopy.

Authors:  M Ala-Korpela; P Posio; S Mattila; A Korhonen; S R Williams
Journal:  J Magn Reson B       Date:  1996-11

4.  Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T.

Authors:  Małgorzata Marjańska; J Riley McCarten; James Hodges; Laura S Hemmy; Andrea Grant; Dinesh K Deelchand; Melissa Terpstra
Journal:  Neuroscience       Date:  2017-05-03       Impact factor: 3.590

5.  Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain.

Authors:  S Blüml; K J Seymour; B D Ross
Journal:  Magn Reson Med       Date:  1999-10       Impact factor: 4.668

6.  Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2.

Authors:  Tsuyoshi Osawa; Teppei Shimamura; Kyoko Saito; Yoko Hasegawa; Naoko Ishii; Miyuki Nishida; Ritsuko Ando; Ayano Kondo; Muyassar Anwar; Rika Tsuchida; Shinjiro Hino; Akihisa Sakamoto; Kaori Igarashi; Kaori Saitoh; Keiko Kato; Keiko Endo; Shotaro Yamano; Yasuharu Kanki; Yoshihiro Matsumura; Takashi Minami; Toshiya Tanaka; Motonobu Anai; Youichiro Wada; Hideki Wanibuchi; Mitsuhiro Hayashi; Akinobu Hamada; Masayuki Yoshida; Shinichi Yachida; Mitsuyoshi Nakao; Juro Sakai; Hiroyuki Aburatani; Masabumi Shibuya; Kentaro Hanada; Satoru Miyano; Tomoyoshi Soga; Tatsuhiko Kodama
Journal:  Cell Rep       Date:  2019-10-01       Impact factor: 9.423

7.  Fast computation of full density matrix of multispin systems for spatially localized in vivo magnetic resonance spectroscopy.

Authors:  Yan Zhang; Li An; Jun Shen
Journal:  Med Phys       Date:  2017-07-10       Impact factor: 4.071

8.  Multi-vendor standardized sequence for edited magnetic resonance spectroscopy.

Authors:  Muhammad G Saleh; Daniel Rimbault; Mark Mikkelsen; Georg Oeltzschner; Anna M Wang; Dengrong Jiang; Ali Alhamud; Jamie Near; Michael Schär; Ralph Noeske; James B Murdoch; Lars Ersland; Alexander R Craven; Gerard Eric Dwyer; Eli Renate Grüner; Li Pan; Sinyeob Ahn; Richard A E Edden
Journal:  Neuroimage       Date:  2019-01-22       Impact factor: 6.556

Review 9.  Motion correction in magnetic resonance spectroscopy.

Authors:  Muhammad G Saleh; Richard A E Edden; Linda Chang; Thomas Ernst
Journal:  Magn Reson Med       Date:  2020-04-17       Impact factor: 3.737

10.  Imaging neuroinflammation? A perspective from MR spectroscopy.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Brain Pathol       Date:  2014-11       Impact factor: 6.508

View more
  1 in total

1.  Importance of Linear Combination Modeling for Quantification of Glutathione and γ-Aminobutyric Acid Levels Using Hadamard-Edited Magnetic Resonance Spectroscopy.

Authors:  Yulu Song; Helge J Zöllner; Steve C N Hui; Kathleen Hupfeld; Georg Oeltzschner; James J Prisciandaro; Richard Edden
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.